Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Alfresa Holdings Corp (2784)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,390.0 +39.5    +1.68%
02/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3126340003 
  • Volume: 605,300
  • Bid/Ask: 2,386.0 / 2,392.5
  • Day's Range: 2,366.5 - 2,390.0
Alfresa Holdings Corp 2,390.0 +39.5 +1.68%

Alfresa Holdings Corp Company Profile

 
Get an in-depth profile of Alfresa Holdings Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

11772

Equity Type

ORD

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company’s medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.

Contact Information

Address 1-1-3 Otemachi Chiyoda-ku
Tokyo, 100-0004
Japan
Phone 81 3 5219 5100
Fax -

Top Executives

Name Age Since Title
Ryuji Arakawa 59 2016 President & Representative Director
Koichi Shimada - 2018 Director
Hisashi Katsuki - 2017 Director
Toshie Takeuchi - 2020 Independent Outside Director
Takashi Hara - 2020 Independent Outside Director
Manabu Kinoshita - 2020 Independent Outside Director
Shigeki Ohashi - 2022 VP, Exe. Officer of Grp Bus, Affiliate Control, Bus Dev & International Business and Director
Kimiko Kunimasa - 2022 Independent Outside Director
Toshiki Tanaka - 2022 VP, Executive Officer of Gen Affairs, HR Planning, Digital Transformation (DX) and Compliance & Dir
Hiroshi Kizaki 64 2023 Outside Audit & Supervisory Board Member
Takashi Ito - 2018 Outside Audit & Supervisory Board Member
Yuji Ueda - 2022 Standing Audit & Supervisory Board Member
Masakazu Ozaki - 2020 Standing Audit & Supervisory Board Member
Seiichi Kishida 63 2019 Executive VP, Assistant to the President & Representative Director
Yusuke Fukujin 47 2020 Executive VP & Representative Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2784 Comments

Write your thoughts about Alfresa Holdings Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email